Why Heart and Kidney Health Matter More for People with Type 1 Diabetes
People with Type 1 diabetes face higher risks of heart disease and kidney damage than the general population. New research is bringing these often-overlooked complications into focus.
Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.
Key takeaways
- Type 1 diabetes significantly increases the risk of cardiovascular disease, heart failure, and chronic kidney disease
- Until recently, most research on protective treatments excluded people with Type 1 diabetes, leaving a gap in available options
- The Type 2 diabetes field has made major advances in heart and kidney protection; similar research is now urgently needed for Type 1
- Understanding these risks is the first step toward better prevention and treatment strategies
A Long-Overlooked Threat
When people think about Type 1 diabetes complications, they often focus on blood sugar management. But emerging research highlights a serious concern that has received less attention: the elevated risk of heart disease and kidney damage in people living with Type 1.
Cardiovascular disease, heart failure, and chronic kidney disease all occur at higher rates in the Type 1 diabetes population. Yet for years, these risks were largely studied in people with Type 2 diabetes, leaving a significant gap in our understanding of how to best protect people with Type 1.
A Treatment Gap
Over the past decade, Type 2 diabetes treatment has been transformed by new medications that do more than simply lower blood sugar. These drugs have been shown to provide important protection for both the heart and kidneys—benefits that go beyond what traditional glucose control alone offers.
However, most of the major clinical trials testing these protective effects deliberately excluded people with Type 1 diabetes. This means that while people with Type 2 have access to treatments with proven heart and kidney benefits, people with Type 1 have largely been left out of this research progress.
Why This Matters Now
Recognizing the high risk of cardiovascular and kidney disease in Type 1 diabetes is crucial—both for patients who want to understand their health and for researchers developing new treatments. The evidence is clear that these complications deserve the same urgent attention that transformed Type 2 diabetes care.
Moving forward, the Type 1 diabetes research community is beginning to include people with Type 1 in trials that evaluate how new treatments might protect the heart and kidneys. This shift could eventually expand treatment options and improve long-term health outcomes for people living with Type 1 diabetes.
Evidence label
Source: Endocrinology and metabolism clinics of North America. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
Related reading
More evidence-labeled coverage across the Type1Cure library.
- Causes & What We KnowPregnant Women with Diabetes Show Higher Rates of Toxoplasma InfectionPubMed indexed literature
- Causes & What We KnowExploring Rare Breast Inflammation: What BRCA Mutations and Type 1 Diabetes May SharePubMed indexed literature
- Causes & What We KnowUnderstanding Type 1 Diabetes: A Shift Toward Early InterventionPubMed indexed literature
- Causes & What We KnowHow Nutrition, Metabolism, and Immunity Connect: What the Lectin Pathway Tells UsPubMed indexed literature
- Causes & What We KnowLiver Changes in Cystic Fibrosis: What a New Study FoundPubMed indexed literature
- Causes & What We KnowWhy Do Finland and Sardinia Have So Much Type 1 Diabetes? Genetics Offers a New CluePubMed indexed literature